Oramed Pharma (ORMP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.33 +0.03 (+1.30%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.33 unch (unch) 16:00 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,103 | 5,088 | -37,764 | -12,255 | -22,989 |
| Depreciation Amortization | 193 | 196 | 58 | 18 | 77 |
| Other Working Capital | 3,200 | -2,696 | -943 | -699 | -1,315 |
| Other Operating Activity | 7,298 | -12,883 | 10,731 | 1,814 | 3,046 |
| Operating Cash Flow | $-8,412 | $-10,295 | $-27,918 | $-11,122 | $-21,181 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,702 | 18,391 | 26,500 | -100,000 | 1,612 |
| PPE Investments | -18 | -254 | -472 | -9 | -375 |
| Purchase Of Investment | -1,307 | -99,550 | -2,705 | N/A | -25,000 |
| Sale Of Investment | 64,500 | 5,000 | N/A | N/A | N/A |
| Other Investing Activity | -60 | 3,375 | 6,888 | 761 | -1 |
| Investing Cash Flow | $105,817 | $-73,038 | $30,211 | $-99,248 | $-23,764 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 99,550 | N/A | N/A | N/A |
| Debt Repayment | -49,550 | -50,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,428 | 11,562 | 60,572 | 101,392 |
| Common Stock Repurchased | -2,484 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -2 | 0 | -783 | 0 | 1,500 |
| Financing Cash Flow | $-52,036 | $51,978 | $10,779 | $60,572 | $102,892 |
| Exchange Rate Effect | -4 | -54 | -64 | 9 | 2 |
| Beginning Cash Position | 9,055 | 40,464 | 27,456 | 77,245 | 19,296 |
| End Cash Position | 54,420 | 9,055 | 40,464 | 27,456 | 77,245 |
| Net Cash Flow | $45,365 | $-31,409 | $13,008 | $-49,789 | $57,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,412 | -10,295 | -27,918 | -11,122 | -21,181 |
| Capital Expenditure | -18 | -254 | -496 | -9 | -375 |
| Free Cash Flow | -8,430 | -10,549 | -28,414 | -11,131 | -21,556 |